ASX - By Stock
|
PWN |
Re:
Ann: Parkway launches Parkway Process Solutions
|
|
Ricksanchezc137
|
61 |
16K |
11 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
61
|
16K
|
11
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway launches Parkway Process Solutions
|
|
Ricksanchezc137
|
61 |
16K |
1 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
61
|
16K
|
1
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway launches Parkway Process Solutions
|
|
Ricksanchezc137
|
61 |
16K |
9 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
61
|
16K
|
9
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway launches Parkway Process Solutions
|
|
Ricksanchezc137
|
61 |
16K |
16 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
61
|
16K
|
16
|
|
ASX - By Stock
|
PWN |
Re:
Ann: Parkway launches Parkway Process Solutions
|
|
Ricksanchezc137
|
61 |
16K |
8 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
61
|
16K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
New Alzheimer's drug may be a catastrophe in the making
|
|
Ricksanchezc137
|
42 |
16K |
5 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
42
|
16K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
New Alzheimer's drug may be a catastrophe in the making
|
|
Ricksanchezc137
|
42 |
16K |
3 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
42
|
16K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen receives positive Pre-IND FDA advice for FXS
|
|
Ricksanchezc137
|
21 |
6.9K |
13 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
21
|
6.9K
|
13
|
|
ASX - By Stock
|
ACW |
Re:
Partnerships with ACW?
|
|
Ricksanchezc137
|
20 |
7.3K |
1 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
20
|
7.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Partnerships with ACW?
|
|
Ricksanchezc137
|
20 |
7.3K |
1 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
20
|
7.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Valuing An Early Stage Pharma
|
|
Ricksanchezc137
|
40 |
13K |
9 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
40
|
13K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
Partnerships with ACW?
|
|
Ricksanchezc137
|
20 |
7.3K |
4 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
20
|
7.3K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Partnerships with ACW?
|
|
Ricksanchezc137
|
20 |
7.3K |
7 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
20
|
7.3K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Under valued stock
|
|
Ricksanchezc137
|
176 |
66K |
6 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
176
|
66K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen Ethics Committee approval for XanaMIA study
|
|
Ricksanchezc137
|
41 |
16K |
15 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
41
|
16K
|
15
|
|
ASX - By Stock
|
ACW |
Re:
where's the news on this??
|
|
Ricksanchezc137
|
123 |
41K |
6 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
123
|
41K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
2 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
194
|
38K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
7 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
194
|
38K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
3 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
3 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
2 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
3 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
7 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
2 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Strategic Update & Teleconference Call Notification
|
|
Ricksanchezc137
|
194 |
38K |
4 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
194
|
38K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
3 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
0 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
0 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
0 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2020 and outlook
|
|
Ricksanchezc137
|
59 |
21K |
1 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
59
|
21K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Review of 2020 and outlook
|
|
Ricksanchezc137
|
59 |
21K |
2 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
59
|
21K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
3 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
130
|
37K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
8 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
130
|
37K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 3Y - Dr George Morstyn
|
|
Ricksanchezc137
|
44 |
16K |
3 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
44
|
16K
|
3
|
|
Charts
|
ACW |
Re:
Chart
|
|
Ricksanchezc137
|
267 |
130K |
13 |
26/03/21 |
26/03/21 |
Charts
|
267
|
130K
|
13
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
3 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
130
|
37K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
0 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
2 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
130
|
37K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
6 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
130
|
37K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
1 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
130
|
37K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
2 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
130
|
37K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
3 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
130
|
37K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Dr Steven Gourlay as CEO
|
|
Ricksanchezc137
|
130 |
37K |
7 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
130
|
37K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer
|
|
Ricksanchezc137
|
164 |
56K |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
164
|
56K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer
|
|
Ricksanchezc137
|
164 |
56K |
5 |
07/03/21 |
07/03/21 |
ASX - By Stock
|
164
|
56K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer
|
|
Ricksanchezc137
|
164 |
56K |
5 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
164
|
56K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Appendix 4D & Half-Year Financial Statements
|
|
Ricksanchezc137
|
4 |
2.7K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
4
|
2.7K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Resignation of Dr Bill Ketelbey as Chief Executive Officer
|
|
Ricksanchezc137
|
164 |
56K |
1 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
164
|
56K
|
1
|
|